Edition:
India

GNC Holdings Inc (GNC.N)

GNC.N on New York Stock Exchange

3.78USD
20 Apr 2018
Change (% chg)

$0.02 (+0.53%)
Prev Close
$3.76
Open
$3.75
Day's High
$3.95
Day's Low
$3.75
Volume
387,458
Avg. Vol
865,512
52-wk High
$10.95
52-wk Low
$3.13

Chart for

About

GNC Holdings, Inc. is a specialty retailer of health, wellness and performance products, which include protein, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty, food and drink and other general merchandise. The Company's operations consist of purchasing... (more)

Overall

Beta: 0.91
Market Cap(Mil.): $586.09
Shares Outstanding(Mil.): 68.47
Dividend: --
Yield (%): --

Financials

  GNC.N Industry Sector
P/E (TTM): -- 44.99 40.93
EPS (TTM): -5.30 -- --
ROI: -17.84 5.13 62.12
ROE: -258.25 9.36 73.69

BRIEF-GNC Announces Plans To Expand Into Australia

* GENERAL NUTRITION CORPORATION ANNOUNCED PLANS TO ESTABLISH, DEVELOP PRESENCE IN AUSTRALIAN MARKET

05 Apr 2018

BRIEF-GNC Holdings ‍Expects To Increase To Over 4,000 Retail Outlets Across India By 2020​

* GNC HOLDINGS INC - ‍EXPECTED TO INCREASE TO OVER 4,000 RETAIL OUTLETS ACROSS INDIA BY 2020​

09 Mar 2018

GNC tweaks maturity extension amendment to thwart holdouts

NEW YORK, Feb 21 (LPC) - Ailing US vitamin and supplement retailer GNC Holdings Inc has sweetened the terms of a complex amendment to its existing credit agreement to extend a looming March 2019 debt maturity, after early consents from lenders fell short of a required threshold, according to three sources familiar with the transaction.

22 Feb 2018

BRIEF-Harbin Pharma Scraps Plan For Unit To Bid For GNC's China Business

* SAYS CONTROLLING SHAREHOLDER SIGNS AGREEMENT TO BUY GNC HOLDINGS' CONVERTIBLE PREFERENCE SHARES WORTH $299.95 MILLION

14 Feb 2018

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

14 Feb 2018

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG, Feb 14 China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

14 Feb 2018

BRIEF-GNC Holdings Says Launched Certain Amendments To Credit Agreement

* GNC HOLDINGS SAYS LAUNCHED CERTAIN AMENDMENTS TO CREDIT AGREEMENT DATED AS OF NOV 26, 2013​ - SEC FILING

14 Feb 2018

BRIEF-GNC Holdings Says On Deal Termination Co to Pay Termination Fee Of Either $10 Mln Or $18 Mln To Harbin Pharmaceutical

* GNC HOLDINGS - ON DEAL TERMINATION UNDER CIRCUMSTANCES, CO WILL PAY FEE OF EITHER $10 MILLION OR $18 MILLION TO HARBIN PHARMACEUTICAL GROUP - SEC FILING Source text: (http://bit.ly/2o4g6KY) Further company coverage:

14 Feb 2018

BRIEF-GNC And Harbin Pharmaceutical Announce $300 Mln Strategic Investment

* GNC AND HARBIN PHARMACEUTICAL ANNOUNCE $300 MILLION STRATEGIC INVESTMENT AND CHINA JOINT VENTURE

13 Feb 2018

BRIEF-GNC Holdings Q4 Loss Per Share $2.99

* GNC HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

13 Feb 2018

Competitors

  Price Chg
SHAKLEE GLOBAL GROUP,INC. (8205.T) ¥10,200 -280.00
Kenko.com,Inc. (3325.T) -- --

Earnings vs. Estimates